Skip to main content
. 2016 Oct 3;9(3):87–102. doi: 10.3727/215517916X693069

Table 10.

Secondary Efficacy Variable: Angiography

Visit 7 (Week 24) +0 [n (%)] +1 [n (%)] +2 [n (%)] +3 [n (%)]
ITT set (N = 15*)
 Visit 1 (screening)
  +0 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00)
  +1 0 (0.00) 3 (20.00) 0 (0.00) 0 (0.00)
  +2 0 (0.00) 0 (0.00) 5 (33.33) 1 (6.67)
  +3 0 (0.00) 0 (0.00) 0 (0.00) 6 (40.00)
  p Value 0.8013
mITT set (N = 15)
 Visit 1 (screening)
  +0 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00)
  +1 0 (0.00) 3 (20.00) 0 (0.00) 0 (0.00)
  +2 0 (0.00) 0 (0.00) 5 (33.33) 1 (6.67)
  +3 0 (0.00) 0 (0.00) 0 (0.00) 6 (40.00)
  p Value 0.8013
PP set (N = 14)
 Visit 1 (screening)
  +0 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00)
  +1 0 (0.00) 2 (14.29) 0 (0.00) 0 (0.00)
  +2 0 (0.00) 0 (0.00) 5 (35.71) 1 (7.14)
  +3 0 (0.00) 0 (0.00) 0 (0.00) 6 (42.86)
  p Value 0.8013

ITT, intention to treat; mITT, modified intention to treat; PP, per protocol. +0: no collateral development; +1: slight collateral development; +2: moderate collateral development; +3: rich collateral development; McNemar Bowker’s test.

*

Two patients not included.